On the other hand, there was an increasing trend toward increased LRO risk in patients who carried more CMRFs than in those without any CMRF (aHR/CI: 1.35/1.02–1.78, 1.48/1.11–1.97, and 1.53/1.15–2.05 for 1, 2, and ≥ 3 CMRFs, respectively) (Table 2 and Figure 2C ). 3.4.
← all excerpts
Impact of Cardiometabolic Risk Factors and Steatotic Liver Disease on Liver-Related Outcomes in Patients With Chronic Hepatitis C After Curative Antiviral Therapy.
1
—
—